SOURCE: Bederra Corporation

Bederra Corporation

March 09, 2010 10:00 ET

Bederra Corporation Issues PR Clarification and Addresses Stock Performance

HOUSTON, TX--(Marketwire - March 9, 2010) - Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas based diversified medical services provider, issued the following announcement as clarification regarding the press release dated February 26, 2010 with the headline "Bederra Corporation Re-Emerges On Newly Implemented Uptick Light Rule." Management stated that the press release was not issued, authorized or otherwise approved by management previous to its dissemination at Management desired to clarify that it has not engaged or otherwise compensated or its principals or agents for any research reports, coverage, and promotion or press release dissemination. Furthermore, the company had no knowledge of the press release prior to its dissemination.

Management further stated that it is not surprised by such coverage of "short volume" and "short interest" by research groups who search for companies on FINRA's REG SHO list. Such analysts use technical analysis and short volume data to ascertain what they believe will be a "squeeze trigger price" per share that will trigger a "buy in" of a company's shares whereupon large short and or naked short sale positions are finally covered resulting in a substantial spike in the price per share on increased liquidity. Bederra management reiterated that it is very concerned about the company's continued presence on the REG SHO list and believes that such a buy-in is imminent, if not underway already, as evidenced by the company's greatly increased liquidity and enhanced price per share in recent trading sessions. The company is weighing the short and long-term effects of any short and/or naked short sales on the company's price per share and its impact on shareholder value and the company's previously announced buy back and vice versa. "While short sales have their place in legitimate market practices, naked short sales are effectively the introduction of counterfeited shares into the market place by unscrupulous individuals and institutions, threatening the foundation of our financial market places and undermining long term shareholder value."

In an effort to maintain ongoing transparency with shareholders and to clarify what action(s) may be necessary to deter any naked short sales of Bederra common stock, the company has initiated its own investigation into the purported activity. The company has also been in contact with regulatory officials in order to better understand publicly available information, and celebrates the February 24th SEC adoption of Rule 201, the alternative "Uptick Rule" designed to restrict destructive short selling: ( Based on the daily trading data from FINRA, it appears that the company has been on the REGSHO list for 56 consecutive trading days and that the company has had 2,154,800,548 shares "fail to deliver" (i.e. fail to be covered) from 14 Dec 2009 through the close of business 2 Mar 2010. As of this point regulators and management alike have no way to precisely quantify the amount of cumulative shares that remain to be covered. However, the short volume for individual months can be viewed on FINRA's website at the following links:

Furthermore, management stated that regarding the company's recently announced share buy back program, the company reports that it has obtained financing from private investors to go forward with the purchase of shares. The company will initiate a common share buy back program using a percentage of both future revenues and financing options to purchase up to 50 percent of its outstanding "public float" -- the free trading share component of the total shares issued and outstanding.

About Bederra Corp.

Bederra Corporation provides multiple modality diagnostic medical imaging services to the greater Houston area and the world famous Texas Medical Center. The Company's business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information